Fatty acid metabolism, 3,2-trans-enoyl-CoA isomerase, mitochondrial
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 18 |
| NetGPI | no | yes: 0, no: 18 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 2 |
| GO:0110165 | cellular anatomical entity | 1 | 4 |
| GO:0005739 | mitochondrion | 5 | 2 |
| GO:0043226 | organelle | 2 | 2 |
| GO:0043227 | membrane-bounded organelle | 3 | 2 |
| GO:0043229 | intracellular organelle | 3 | 2 |
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pescher et al. (upgregulation) | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A4I738
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006082 | organic acid metabolic process | 3 | 2 |
| GO:0006629 | lipid metabolic process | 3 | 2 |
| GO:0006631 | fatty acid metabolic process | 4 | 2 |
| GO:0006635 | fatty acid beta-oxidation | 6 | 2 |
| GO:0008152 | metabolic process | 1 | 2 |
| GO:0009056 | catabolic process | 2 | 2 |
| GO:0009062 | fatty acid catabolic process | 5 | 2 |
| GO:0009987 | cellular process | 1 | 2 |
| GO:0016042 | lipid catabolic process | 4 | 2 |
| GO:0016054 | organic acid catabolic process | 4 | 2 |
| GO:0019395 | fatty acid oxidation | 5 | 2 |
| GO:0019752 | carboxylic acid metabolic process | 5 | 2 |
| GO:0030258 | lipid modification | 4 | 2 |
| GO:0032787 | monocarboxylic acid metabolic process | 6 | 2 |
| GO:0034440 | lipid oxidation | 5 | 2 |
| GO:0043436 | oxoacid metabolic process | 4 | 2 |
| GO:0044237 | cellular metabolic process | 2 | 2 |
| GO:0044238 | primary metabolic process | 2 | 2 |
| GO:0044242 | cellular lipid catabolic process | 4 | 2 |
| GO:0044248 | cellular catabolic process | 3 | 2 |
| GO:0044255 | cellular lipid metabolic process | 3 | 2 |
| GO:0044281 | small molecule metabolic process | 2 | 2 |
| GO:0044282 | small molecule catabolic process | 3 | 2 |
| GO:0046395 | carboxylic acid catabolic process | 5 | 2 |
| GO:0071704 | organic substance metabolic process | 2 | 2 |
| GO:0072329 | monocarboxylic acid catabolic process | 6 | 2 |
| GO:1901575 | organic substance catabolic process | 3 | 2 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 19 |
| GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity | 5 | 5 |
| GO:0004165 | delta(3)-delta(2)-enoyl-CoA isomerase activity | 5 | 12 |
| GO:0016491 | oxidoreductase activity | 2 | 5 |
| GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 3 | 5 |
| GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4 | 5 |
| GO:0016853 | isomerase activity | 2 | 19 |
| GO:0016860 | intramolecular oxidoreductase activity | 3 | 12 |
| GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds | 4 | 12 |
| GO:0004300 | enoyl-CoA hydratase activity | 5 | 2 |
| GO:0016829 | lyase activity | 2 | 2 |
| GO:0016835 | carbon-oxygen lyase activity | 3 | 2 |
| GO:0016836 | hydro-lyase activity | 4 | 2 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.638 |
| CLV_NRD_NRD_1 | 295 | 297 | PF00675 | 0.381 |
| CLV_NRD_NRD_1 | 347 | 349 | PF00675 | 0.645 |
| CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.639 |
| CLV_PCSK_KEX2_1 | 295 | 297 | PF00082 | 0.367 |
| CLV_PCSK_KEX2_1 | 61 | 63 | PF00082 | 0.590 |
| CLV_PCSK_PC1ET2_1 | 61 | 63 | PF00082 | 0.590 |
| CLV_PCSK_SKI1_1 | 43 | 47 | PF00082 | 0.523 |
| CLV_PCSK_SKI1_1 | 90 | 94 | PF00082 | 0.378 |
| DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.659 |
| DEG_SPOP_SBC_1 | 4 | 8 | PF00917 | 0.761 |
| DOC_CYCLIN_RxL_1 | 243 | 254 | PF00134 | 0.328 |
| DOC_CYCLIN_yClb5_NLxxxL_5 | 334 | 340 | PF00134 | 0.459 |
| DOC_PP2B_LxvP_1 | 226 | 229 | PF13499 | 0.406 |
| DOC_PP2B_LxvP_1 | 288 | 291 | PF13499 | 0.403 |
| DOC_PP4_FxxP_1 | 173 | 176 | PF00568 | 0.330 |
| DOC_PP4_FxxP_1 | 70 | 73 | PF00568 | 0.502 |
| DOC_USP7_MATH_1 | 101 | 105 | PF00917 | 0.322 |
| DOC_USP7_MATH_1 | 4 | 8 | PF00917 | 0.622 |
| DOC_USP7_MATH_1 | 57 | 61 | PF00917 | 0.605 |
| DOC_WW_Pin1_4 | 182 | 187 | PF00397 | 0.305 |
| DOC_WW_Pin1_4 | 251 | 256 | PF00397 | 0.353 |
| LIG_14-3-3_CanoR_1 | 11 | 17 | PF00244 | 0.610 |
| LIG_14-3-3_CanoR_1 | 286 | 291 | PF00244 | 0.447 |
| LIG_14-3-3_CanoR_1 | 308 | 318 | PF00244 | 0.265 |
| LIG_APCC_ABBA_1 | 107 | 112 | PF00400 | 0.337 |
| LIG_BIR_III_2 | 65 | 69 | PF00653 | 0.628 |
| LIG_BRCT_BRCA1_1 | 19 | 23 | PF00533 | 0.556 |
| LIG_deltaCOP1_diTrp_1 | 165 | 173 | PF00928 | 0.330 |
| LIG_FHA_1 | 124 | 130 | PF00498 | 0.376 |
| LIG_FHA_1 | 13 | 19 | PF00498 | 0.742 |
| LIG_FHA_2 | 310 | 316 | PF00498 | 0.341 |
| LIG_LIR_Apic_2 | 172 | 176 | PF02991 | 0.351 |
| LIG_LIR_Apic_2 | 69 | 73 | PF02991 | 0.530 |
| LIG_LIR_Gen_1 | 108 | 118 | PF02991 | 0.342 |
| LIG_LIR_Gen_1 | 162 | 170 | PF02991 | 0.352 |
| LIG_LIR_Gen_1 | 285 | 294 | PF02991 | 0.330 |
| LIG_LIR_Gen_1 | 305 | 311 | PF02991 | 0.394 |
| LIG_LIR_Nem_3 | 108 | 113 | PF02991 | 0.342 |
| LIG_LIR_Nem_3 | 165 | 170 | PF02991 | 0.345 |
| LIG_LIR_Nem_3 | 285 | 290 | PF02991 | 0.330 |
| LIG_LIR_Nem_3 | 305 | 309 | PF02991 | 0.348 |
| LIG_LIR_Nem_3 | 320 | 326 | PF02991 | 0.429 |
| LIG_LYPXL_SIV_4 | 280 | 288 | PF13949 | 0.476 |
| LIG_PCNA_PIPBox_1 | 333 | 342 | PF02747 | 0.403 |
| LIG_PCNA_yPIPBox_3 | 329 | 340 | PF02747 | 0.366 |
| LIG_Pex14_2 | 159 | 163 | PF04695 | 0.330 |
| LIG_SH2_CRK | 236 | 240 | PF00017 | 0.325 |
| LIG_SH2_STAP1 | 236 | 240 | PF00017 | 0.325 |
| LIG_SH2_STAP1 | 318 | 322 | PF00017 | 0.318 |
| LIG_SH2_STAT3 | 28 | 31 | PF00017 | 0.681 |
| LIG_SH2_STAT5 | 238 | 241 | PF00017 | 0.342 |
| LIG_SH2_STAT5 | 306 | 309 | PF00017 | 0.430 |
| LIG_SH2_STAT5 | 339 | 342 | PF00017 | 0.379 |
| LIG_SH3_3 | 145 | 151 | PF00018 | 0.476 |
| LIG_SH3_3 | 224 | 230 | PF00018 | 0.438 |
| LIG_SH3_3 | 33 | 39 | PF00018 | 0.612 |
| LIG_SH3_3 | 70 | 76 | PF00018 | 0.497 |
| LIG_SxIP_EBH_1 | 127 | 141 | PF03271 | 0.343 |
| LIG_TRAF2_1 | 162 | 165 | PF00917 | 0.320 |
| LIG_TRAF2_1 | 271 | 274 | PF00917 | 0.517 |
| LIG_TRFH_1 | 326 | 330 | PF08558 | 0.250 |
| LIG_UBA3_1 | 82 | 90 | PF00899 | 0.385 |
| MOD_CK1_1 | 60 | 66 | PF00069 | 0.649 |
| MOD_CK1_1 | 7 | 13 | PF00069 | 0.776 |
| MOD_CK2_1 | 159 | 165 | PF00069 | 0.410 |
| MOD_CK2_1 | 272 | 278 | PF00069 | 0.479 |
| MOD_CK2_1 | 335 | 341 | PF00069 | 0.340 |
| MOD_CMANNOS | 116 | 119 | PF00535 | 0.353 |
| MOD_GlcNHglycan | 132 | 135 | PF01048 | 0.379 |
| MOD_GlcNHglycan | 139 | 142 | PF01048 | 0.330 |
| MOD_GlcNHglycan | 19 | 22 | PF01048 | 0.649 |
| MOD_GSK3_1 | 130 | 137 | PF00069 | 0.323 |
| MOD_GSK3_1 | 3 | 10 | PF00069 | 0.744 |
| MOD_GSK3_1 | 317 | 324 | PF00069 | 0.466 |
| MOD_N-GLC_1 | 219 | 224 | PF02516 | 0.335 |
| MOD_NEK2_1 | 159 | 164 | PF00069 | 0.342 |
| MOD_NEK2_1 | 219 | 224 | PF00069 | 0.348 |
| MOD_NEK2_1 | 23 | 28 | PF00069 | 0.543 |
| MOD_NEK2_1 | 239 | 244 | PF00069 | 0.185 |
| MOD_PIKK_1 | 23 | 29 | PF00454 | 0.601 |
| MOD_PIKK_1 | 321 | 327 | PF00454 | 0.330 |
| MOD_PK_1 | 286 | 292 | PF00069 | 0.434 |
| MOD_PKA_1 | 74 | 80 | PF00069 | 0.636 |
| MOD_Plk_1 | 272 | 278 | PF00069 | 0.488 |
| MOD_Plk_2-3 | 273 | 279 | PF00069 | 0.338 |
| MOD_Plk_4 | 134 | 140 | PF00069 | 0.349 |
| MOD_Plk_4 | 335 | 341 | PF00069 | 0.340 |
| MOD_ProDKin_1 | 182 | 188 | PF00069 | 0.305 |
| MOD_ProDKin_1 | 251 | 257 | PF00069 | 0.353 |
| MOD_SUMO_rev_2 | 124 | 129 | PF00179 | 0.436 |
| TRG_DiLeu_BaEn_1 | 305 | 310 | PF01217 | 0.265 |
| TRG_DiLeu_LyEn_5 | 305 | 310 | PF01217 | 0.265 |
| TRG_ENDOCYTIC_2 | 198 | 201 | PF00928 | 0.476 |
| TRG_ENDOCYTIC_2 | 236 | 239 | PF00928 | 0.340 |
| TRG_ENDOCYTIC_2 | 306 | 309 | PF00928 | 0.430 |
| TRG_ER_diArg_1 | 1 | 3 | PF00400 | 0.642 |
| TRG_ER_diArg_1 | 295 | 297 | PF00400 | 0.363 |
| TRG_Pf-PMV_PEXEL_1 | 308 | 313 | PF00026 | 0.429 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1I4C8 | Leptomonas seymouri | 72% | 99% |
| A0A0S4IKH3 | Bodo saltans | 57% | 100% |
| A0A0S4JA19 | Bodo saltans | 35% | 100% |
| A0A1X0NRI1 | Trypanosomatidae | 52% | 95% |
| A0A1X0P9A2 | Trypanosomatidae | 25% | 100% |
| A0A3Q8IE71 | Leishmania donovani | 35% | 100% |
| A0A3Q8IIZ5 | Leishmania donovani | 26% | 100% |
| A0A3Q8IV04 | Leishmania donovani | 28% | 100% |
| A0A3R7N7B2 | Trypanosoma rangeli | 25% | 100% |
| A0A3S7X4R5 | Leishmania donovani | 91% | 100% |
| A0A3S7X4T7 | Leishmania donovani | 88% | 100% |
| A0A422N418 | Trypanosoma rangeli | 59% | 100% |
| A0A422NUW6 | Trypanosoma rangeli | 32% | 100% |
| A1KN36 | Mycobacterium bovis (strain BCG / Pasteur 1173P2) | 27% | 100% |
| A4HH09 | Leishmania braziliensis | 34% | 100% |
| A4HJK3 | Leishmania braziliensis | 72% | 98% |
| A4HJK8 | Leishmania braziliensis | 76% | 98% |
| A4HJL5 | Leishmania braziliensis | 72% | 98% |
| A4I438 | Leishmania infantum | 34% | 100% |
| A4I4U5 | Leishmania infantum | 26% | 100% |
| A4I708 | Leishmania infantum | 91% | 98% |
| A5U753 | Mycobacterium tuberculosis (strain ATCC 25177 / H37Ra) | 27% | 100% |
| A9JS71 | Xenopus laevis | 26% | 100% |
| C9ZKS4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 29% | 100% |
| C9ZME0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 62% | 74% |
| C9ZWP5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 58% | 97% |
| E9ADK3 | Leishmania major | 33% | 100% |
| E9AE93 | Leishmania major | 27% | 100% |
| E9AEL3 | Leishmania major | 27% | 100% |
| E9AHU0 | Leishmania infantum | 28% | 100% |
| E9ALJ3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 26% | 100% |
| E9AM78 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 34% | 100% |
| E9B226 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 98% |
| E9B233 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 82% | 97% |
| E9B5S4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
| O07137 | Mycobacterium leprae (strain TN) | 22% | 100% |
| O35459 | Mus musculus | 22% | 100% |
| P14604 | Rattus norvegicus | 24% | 100% |
| P23965 | Rattus norvegicus | 39% | 100% |
| P30084 | Homo sapiens | 23% | 100% |
| P34559 | Caenorhabditis elegans | 21% | 100% |
| P42125 | Mus musculus | 38% | 100% |
| P42126 | Homo sapiens | 38% | 100% |
| P52046 | Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787) | 22% | 100% |
| P64017 | Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) | 22% | 100% |
| P9WNN2 | Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) | 27% | 100% |
| P9WNN3 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 27% | 100% |
| P9WNN8 | Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) | 22% | 100% |
| P9WNN9 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 22% | 100% |
| Q0AVM1 | Syntrophomonas wolfei subsp. wolfei (strain DSM 2245B / Goettingen) | 25% | 100% |
| Q1ZXF1 | Dictyostelium discoideum | 24% | 100% |
| Q4Q628 | Leishmania major | 90% | 100% |
| Q4Q636 | Leishmania major | 87% | 100% |
| Q52995 | Rhizobium meliloti (strain 1021) | 24% | 100% |
| Q58DM8 | Bos taurus | 24% | 100% |
| Q5R646 | Pongo abelii | 23% | 100% |
| Q62651 | Rattus norvegicus | 22% | 100% |
| Q6AYG5 | Rattus norvegicus | 27% | 100% |
| Q7TXE1 | Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) | 27% | 100% |
| Q8BH95 | Mus musculus | 24% | 100% |
| V5B2L9 | Trypanosoma cruzi | 56% | 89% |
| V5BK92 | Trypanosoma cruzi | 31% | 100% |